Oncotelic Therapeutics, Inc. (OTLC)
0.099
+0.01
(+5.54%)
USD |
OTCM |
Dec 08, 16:00
Oncotelic Therapeutics Shareholders Equity (Quarterly): 9.051M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Johnson & Johnson | 79.28B |
| Eli Lilly & Co. | 23.79B |
| Merck & Co., Inc. | 51.85B |
| Pfizer Inc. | 92.80B |
| NovaBay Pharmaceuticals, Inc. | 1.634M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 28.16M |
| Total Liabilities (Quarterly) | 20.08M |
| Debt to Equity Ratio | 1.607 |
| Current Ratio | 0.0803 |
| Net Debt Paydown Yield | -0.91% |